US Food and Drug Administration

The company said that it is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number -…

SAGE no longer recommends annual COVID-19 vaccine boosters for healthy adults under 60 years of age after they have received both…

The company’s flagship facility was inspected by the USFDA between December 5 and 9, 2022, and a form 483 listing three…

This is the first COVID-19 vaccine authorised in the US for use in this age group

Inovio said, depending on the results of its mid-stage trial, it would run the late-stage study for its vaccine candidate,…

New indication marks secondFDAapproval for Trodelvy in 2021

The drugmaker said the $205 million US extension for 500,000 antibody doses builds on a contract agreed with government agencies…

Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…

Approval based on data from the randomised, double-blind ENSEMBLE PLUS study, showing consistent safety to the conventional…

Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others